Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.824
-0.047 (-5.37%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $7.26 million as of April 28, 2026. Its market cap has decreased by -22.73% in one year.
Market Cap
7.26M
Enterprise Value
240.17K
1-Year Change
-22.73%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $7.26M, a decrease of -74.15%. That is a compound annual growth rate of -14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 7.10M | 57.78% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 7.95M |
| TransCode Therapeutics | 7.94M |
| GridAI Technologies | 7.41M |
| Acurx Pharmaceuticals | 7.36M |
| Aptorum Group | 7.34M |
| Addex Therapeutics | 7.22M |
| Xenetic Biosciences | 7.13M |
| Indaptus Therapeutics | 7.11M |